News

Transform the Future of Health If you have a bold, ambitious idea and feel you would be a good fit for ARPA-H, please complete the form below and submit your cover letter, CV, and idea or concept that addresses the ARPA-(H)eilmeier Questions.

ARPA-H will support concepts brought to life directly from Program Managers that have not only identified a key problem in health today, but are also passionate about a vision to bring forward revolutionary solutions to solve the problem, and do so in an equitable way. ARPA-H embraces a culture of open innovation and empowers its program managers to fearlessly pursue health breakthroughs that cannot readily be accomplished through traditional research or commercial activity.

The Center for Innovative NeuroTech Advancement (CINTA) & NeuroTech Harbor (NTH) announce the 2023 Spring Award Competition supported by the NIH Blueprint MedTech Program

Seeking collaborative projects aimed at developing emerging technologies into commercially viable, clinically focused solutions for disorders of the nervous system that are aligned with the mission and interests of the participating institutes and centers

The current solicitation is open and accepting pre-proposals until March 16th, the next solicitation is expected to be announced in July 2023

The Maryland Department of Commerce is seeking companies to join the Maryland delegation at the BIO International Convention in Boston, MA, June 5-8, 2023.  Our goal is to identify companies that would benefit the most from participation.  If selected, your company will receive one complimentary Premier Access pass, including access to One-on-One Partnering in the Business Forum and Exhibitor Booths, educational content, and networking receptions, as well as inclusion in promotional content.  Selected companies must be registered to do business in Maryland.

I walked into the conference room, eager to hear a presentation on the same topic as my ongoing Ph.D. project. But my enthusiasm didn’t last long. As a scientist with attention-deficit/hyperactivity disorder (ADHD), the text-laden slides were difficult for me to process while I simultaneously tried to listen to what the presenter had to say. My mind began to wander, only to snap back to the talk when I heard the sound of clapping. Afterward, I was faced with awkward conversations during the coffee break as colleagues asked for my opinion on the research and I had no real answer to give them. The experience was frustrating, but it also helped me think about how I can craft my own presentations to interest all scientists—including audience members with ADHD.

Image: https://www.science.org/

Six and a half years ago, Facebook founder and CEO Mark Zuckerberg and his wife, Dr. Priscilla Chan, announced a $3 billion commitment to basic science research over a decade, including $600 million to create a biomedical research hub in San Francisco in collaboration with researchers from the University of California at San Francisco, the University of California at Berkeley and Stanford University. In late 2021 they promised another $3.4 billion toward science.

Image: Angela Detweiler, a scientist in the genome sequencing laboratory at the Chan Zuckerberg Biohub in San Francisco, briefs Mark Zuckerberg and Priscilla Chan, cofounders and co-CEOs of the Chan Zuckerberg Initiative (CZI), on the lab’s instruments.CODY PICKENS FOR FORBES

The Covid 19 pandemic created immense challenges for the Pharmaceutical, Biopharmaceutical and Medical Device Industries, and for companies researching, developing, and manufacturing Rx products around the world. In 2020 and 2021 (and to some degree, continuing today) all processes were dramatically impacted by the pandemic as many employees, consultants, and others were restricted from physically working in the office or manufacturing facility, resulting in skeleton crews and largely remote workers.

“I told Bruce Jarrell, I had told Jennifer [Litchman], please don’t do this. You know, don’t put me on the wall yet!” pleaded University System of Maryland (USM) Chancellor Jay A. Perman, MD, to the laughter of nearly 100 friends, colleagues, and former colleagues at a Feb. 23 ceremony held to unveil his official portrait as a past president of the University of Maryland, Baltimore (UMB). “For God’s sakes, I’m an active faculty member here. I’m not done,” he continued to more laughter.

After Perman and current UMB President Bruce E. Jarrell, MD, FACS, unveiled the portrait together, Perman agreed artist Jacqueline Jasper’s work was “beautiful” and thanked her, still appearing very self-conscious.

If you have a bold, ambitious idea and feel you would be a good fit for ARPA-H, please complete the form below and submit your cover letter, CV, and idea or concept that addresses the ARPA-(H)eilmeier Questions.

ARPA-H will support concepts brought to life directly from Program Managers that have not only identified a key problem in health today, but are also passionate about a vision to bring forward revolutionary solutions to solve the problem, and do so in an equitable way. ARPA-H embraces a culture of open innovation and empowers its program managers to fearlessly pursue health breakthroughs that cannot readily be accomplished through traditional research or commercial activity.

Program managers at ARPA-H will serve a term-limited appointment of three years, and no more than six years total, to ensure a constant rotation of new ideas and diverse perspectives.